RMD · 8-K · 20260806PR337962

FX / Currency Impact

RESMED INC · 2026-08-06 · Importance 31 · Surprise 32

ResMed reported FY2026 revenue growth of 10% to $5.653 billion, compared with 8% growth on a constant-currency basis. In the fourth quarter, revenue increased 9% to $1.464 billion, or 8% on a constant-currency basis. The reported-versus-constant-currency difference indicates a favorable foreign-exchange contribution to reported revenue growth, while Rest of World Sleep and Breathing Health revenue grew 10% in constant currency in the quarter.

Key facts

• Company states constant currency information is calculated by translating current period financial information using foreign exchange rates in effect during the previous comparable period source